Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT06058858
Eligibility Criteria:
Common inclusion criteria :
* Paediatric (1 to 18 years old) receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
* Adult receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
* CMV seropositive patients
Inclusion criteria : retrospective part
* Provide written non-opposition from the patient signed by investigator
* If the patient is a minor, provide written non-opposition from both parents and child (if age appropriate to collect their non-objection) or child and the legal representative in case only one parent is alive, signed by investigator
Inclusion criteria : prospective part
* Provide written consent form signed by patient and investigator
* If the patient is a minor, provide written consent form signed by investigator and both parents or signed by investigator and the legal representative in case only one parent is alive
Exclusion Criteria:
* CMV seronegative patients
* Lack of affiliation to a social security scheme (as a beneficiary or assignee)
* Patients under guardianship / curatorship
* Patient under AME (state medical aid)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
100 Years
Study:
NCT06058858
Study Brief:
Protocol Section:
NCT06058858